NICE recommends Celgene’s Ozanimod to treat ulcerative colitis
pharmaphorum
SEPTEMBER 7, 2022
The FDA had approved the drug for use as UC treatment in the US in May 2021. The recommended initial dosage is low, with a gradual build up in dosage, so as to reduce possible side effects such as upper respiratory infection, urinary tract infection, and hypertension.
Let's personalize your content